Internal Medicine Update

The Patient Did Well — So the Insurance Company Won’t Pay
Dr. Paul Sax highlights the frustrations of peer-to-peer discussions with insurance companies. https://jwat.ch/4eRzVyc

Are GLP-1s the Newest Fertility Treatment? Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are incorporating the medicines into preconception care plans.

In a meta-analysis that included over 3,700 patients with heart failure with preserved ejection fraction (HFpEF) and obesity, semaglutide lowered the rate of worsening HF events compared with placebo.

In a subgroup analysis, patients with body mass index ≥35 kg/m2 were more likely to benefit from semaglutide than those with lower body mass index. In patients with HFpEF and obesity, we suggest a GLP-1 receptor agonist and lifestyle interventions for weight loss rather than lifestyle interventions alone.

Stay with What's New in : https://ow.ly/n4Me50TYtOS